She underwent ERCP at [**Hospital3 417**] Hospital on [**2151-3-29**] with sphincterotomy, brushings and stent placement across a mid-biliary duct stricture.
She was admitted electively on [**2151-5-18**] following her pancreaticoduodenectomy (Whipple procedure).
Submit fluids in a       capped syringe (no needle), red top tube, or sterile cup.
Additional Pathologic Findings:  Chronic pancreatitis, intraductal papillary mucinous tumor with high-grade dysplasia involving main and side branch pancreatic ducts.
[**2151-5-24**] AP CHEST: IMPRESSION: AP chest compared to [**5-23**] and [**5-24**] at 4:37 a.m.:  Small region of heterogeneous opacification at the right lung base has been present for several days.
Brief Hospital Course: NEURO/PAIN: The patient was maintained on IV pain medication in the immediate post-operative period and had an epidural catheter in place in the immediate post-op period; and was transitioned to PO narcotic medication with adequate pain control on POD#[**4-30**].
The patient remained neurologically intact and without change from baseline during their stay.
She did require a minor amount of Neosynephrine gtt IV intra-operatively, but this was weaned without post-op requirement, and she remained hemodynamically stable.
The patient was maintained on IV anti-hypertensive medication in the immediate post-op period, with transition to their oral home anti-hypertensives on POD#[**8-3**].
The patient's home anti-hypertensive medications were resumed on POD#[**8-3**].
RESPIRATORY: he patient was extubated in the immediate post-op period successfully, but given some hypercarbia and carbon dioxide retention attributed to underlying smoking history and likely a COPD component, the patient was 93% on non-rebreather in the PACU and required re-intubation before transfer to the surgical ICU for futher monitoring.
The patient denied cough or respiratory symptoms following this, but continued to require supplemental oxygen.
Pulse oximetry was monitored closely and the patient maintained adequate oxygenation on [**1-29**] liters of nasal cannula supplementation, requiring home oxygen on discharge to rehab.
Intermittent Lasix IV was given for diuresis.
GASTROINTESTINAL: The patient was NPO following their procedure and maintained on IV fluids for hydration while NPO.
Serial abdominal exams were performed, and once flatus resumed, the patient was transitioned to a clear liquid diet and their IV fluids were hep-locked on POD#7.
A nasogastric tube was maintained until the output was minimal, and was removed on POD#3.
The patient was maintained on Octreotide in the post-op period as well, which was discontinued on POD#9.
[**Initials (NamePattern4) **] [**Last Name (NamePattern4) 1661**]-[**Location (un) 1662**]/[**Doctor Last Name 406**] drain remained in place post-operatively, anf the output was greater than 30 cc in a 24-hour period, thus she was discharged with the drain in place.
A Foley catheter was placed intra-operatively and removed on POD#4, at which time the patient was able to successfully void without issue.
The patient received only standard peri-operative antibiotics, and did not require further antibiotics post-op.
Blood glucose levels greater than 120 mg/dL were addressed with an insulin sliding scale.
PROPHYLAXIS: The patient was maintained on heparin 5000 units SQ TID for DVT/PE prophylaxis and encouraged to ambulate immediately post-op once cleared by physical therapy.
GI prophylaxis was sustained with Protonix/Famotidine when necessary.
Medications on Admission: Tylenol 1000 mg PO BID, calcium carbonate PRN, Naprosyn PRN  Discharge Medications: 1. hydromorphone 2 mg Tablet Sig: 1-2 Tablets PO Q3H (every 3 hours) as needed for pain.
Disp:*45 Tablet(s)* Refills:*0* 2. metoprolol tartrate 25 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
3. ipratropium bromide 0.02 % Solution Sig: One (1) nebulizer Inhalation Q6H (every 6 hours) as needed for wheeze/sob.
4. metoclopramide 10 mg Tablet Sig: One (1) Tablet PO four times a day.
5. pantoprazole 40 mg Tablet, Delayed Release (E.C.)
6. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: 1-2 puffs Inhalation every six (6) hours as needed for shortness of breath or wheezing.
Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day.
* Please take any new medications as prescribed.
* Please take the prescribed analgesic medications as needed.
You may not drive or operate heavy machinery while taking narcotic analgesic medications.
